The goal of this observational study is to draw the characteristic maps of imaging omics, genomics, transcriptome, proteomics, pathological omics, metabolomics, etc. of the dynamic evolution of endometrial carcinogenesis in 100 patients with normal endometrium, 100 patients with atypical endometrial hyperplasia, and 100 patients with endometrial cancer; and then to explore the underlying molecular mechanism, and establish the database system for the dynamic evolution of endometrial carcinogenesis.
Study Type
OBSERVATIONAL
Enrollment
300
The mutant genes of participants and their expression as assessed by gene sequencing, RNA sequencing and mass spectrometry analysis
Time frame: August 2023 to June 2026
Differences in the expression of these mutant genes among the three groups of participants as assessed by SAS® 9.4
Time frame: January 2026 to June 2026
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.